DC Strategic Group is a leading global technology and defense innovator, respected for designing solutions to some of our world's most challenging problems, from the reaches of space to an autistic child's reach for learning. And now, we're reaching even further - for a new paradigm in non-antibody vaccine design.
Our human systems are miraculous little works of engineering with dozens to hundreds of pre-programmed responses to fighting disease. And many of us who appear to show 'natural immunity' do not show corresponding Cov-19 antigens or antibodies in their blood. So why would we expect an antibody-based vaccine to be anyone's best solution?
10 years ago we helped the US Navy innovate its first jet biofuel, and the USDOE acquire its first US algae farm. Now, we want to put our algae designs for air, hvac, and water purification into commercial, military, and hospitality living spaces.
Shortly before the recent US-Korean defense summit in Washington, we got a call from Korea, and were pleased to offer Korea any hypersonic strategic defense our innovation might support.
Monthly flea pills work by making our pets toxic to the flea larva. Does this approach hold promise for humans fighting Cov-19?